Evaluation of a low‐dose desoxycorticosterone pivalate treatment protocol for long‐term management of dogs with primary hypoadrenocorticism

BACKGROUND: Lowering the dose of desoxycorticosterone pivalate (DOCP) for the treatment of dogs with primary hypoadrenocorticism (PH) decreases costs and could lead to increased owner motivation to treat their affected dogs. OBJECTIVE: To evaluate the efficacy of a low‐dose DOCP treatment protocol i...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Vet Intern Med
Autori principali: Sieber‐Ruckstuhl, Nadia S., Reusch, Claudia E., Hofer‐Inteeworn, Nathalie, Kuemmerle‐Fraune, Claudia, Müller, Claudia, Hofmann‐Lehmann, Regina, Boretti, Felicitas S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Inc. 2019
Soggetti:
SMALL ANIMAL
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6524388/
https://ncbi.nlm.nih.gov/pubmed/30865322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.15475
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi